Early Phase 1 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People with a confirmed diagnosis of pancreatic adenocarcinoma (a specific type of pancreatic cancer) that has spread or cannot be surgically removed, and where at least one measurable tumour or affected lymph node is visible on scans
- People whose cancer has been shown by CT or MRI scan (taken within the past 28 days) to have continued growing or spreading despite at least one prior treatment
- People with a general health and activity level rated at 2 or below on a standard medical scale, meaning they are able to care for themselves but may not be able to do heavy physical work (confirm with trial site)
- People who have finished their most recent chemotherapy at least 2 weeks before the first scan, and whose side effects from prior treatment have mostly resolved
- People with blood cell counts within an acceptable range, as measured by a blood test (confirm with trial site for specific values)
- People with liver and kidney function within an acceptable range, as measured by a blood test (confirm with trial site for specific values)
- People with a life expectancy of at least 3 months
- People who are able to lie still without moving for 30 to 60 minutes during a scan
- For the treatment phase: people who have already completed the first scan part of the trial, and whose scan shows the cancer is detectable at a level above a set threshold (confirm with trial site)
Who may not be able to join:
- People currently taking blood-thinning or antiplatelet medications, with the exception of low-dose aspirin
- People with severe heart failure (classified as Class 3 or 4 on a standard medical scale)
- People who have had a significant bleed — such as from the stomach, bowel, or brain — within the two weeks before joining the trial
- People who are pregnant or currently breastfeeding
- People who have had a major surgical procedure under general anaesthetic within 28 days before the trial starts, or who are expected to need major surgery within 6 weeks of starting
- People who have another active cancer that has required treatment within the past 2 years
- People with an active, uncontrolled infection caused by bacteria, a virus, or fungus that requires ongoing treatment
- People whose mental health or personal circumstances would make it difficult to follow the trial requirements
- People who have previously had radiation therapy for advanced or metastatic disease
- People who weigh more than 350 pounds (approximately 159 kg), as the scanning equipment has a weight limit
- People whose blood clotting levels fall outside the acceptable range set by the trial (confirm with trial site for specific values)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Julie L Sutcliffe, University of California, Davis
Phone: 916-734-5536
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
[68Ga]Ga DOTA-5G PET/CT imaging; [177Lu]Lu DOTA-ABM-5G dose escalation therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.